ANTI-HIV TYPE-1 CYTOTOXIC T-LYMPHOCYTE EFFECTOR ACTIVITY AND DISEASE PROGRESSION IN THE FIRST 8 YEARS OF HIV TYPE-1 INFECTION OF HOMOSEXUAL MEN

被引:54
作者
RINALDO, CR
BELTZ, LA
HUANG, XL
GUPTA, P
FAN, Z
TORPEY, DJ
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
[2] UNIV PITTSBURGH,SCH MED,DEPT INFECT DIS & MICROBIOL,PITTSBURGH,PA 15261
关键词
D O I
10.1089/aid.1995.11.481
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic T lymphocytes (CTL) may play an important role in host defense against HIV-1 infection, In this study, we examined the responses of circulating effector CTL (CTLe) specific for Gag, Pol, Env, and Tat in 57 HIV-1-infected men, 49 of whom were asymptomatic and had documented time since seroconversion of <8 years, CTLe responses to at least one of the four HIV-1 gene products were detected in 83% of the subjects, The magnitude and prevalence of the anti-Tat responses were significantly less than the responses to Gag, pol, and Env. Cell depletion studies indicated that the lytic activity against the HIV-1 structural proteins was mediated by CD8(+) T cells, although 30% of Env-specific lysis was mediated by CD16(+) natural killer cells, Anti-HIV-1 CTLe responses against Gag and Pol were significantly less in subjects infected for over 6 years as compared to those infected for shorter periods of time, We found no correlation, however, between anti-HIV-1 CTLe responses and either CD4(+) or CD8(+) T cell counts, rates of CD4(+) T cell loss, HIV-1 infectious viral load, use of antiviral medications, or subsequent progression to AIDS, Our results indicate that anti-HIV-1 CTLe activity is relatively stable in asymptomatic subjects infected <6 years, and is not an early marker for risk of disease progression.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 42 条
  • [1] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [2] BUSEYNE F, 1993, J IMMUNOL, V150, P3569
  • [3] HIV-SPECIFIC CD8+ T-CELL IMMUNE-RESPONSES AND VIRAL REPLICATION
    BUSEYNE, F
    RIVIERE, Y
    [J]. AIDS, 1993, 7 : S81 - S85
  • [4] QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE
    CARMICHAEL, A
    JIN, X
    SISSONS, P
    BORYSIEWICZ, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 249 - 256
  • [5] EXPRESSION OF THE HTLV-III ENVELOPE GENE BY A RECOMBINANT VACCINIA VIRUS
    CHAKRABARTI, S
    ROBERTGUROFF, M
    WONGSTAAL, F
    GALLO, RC
    MOSS, B
    [J]. NATURE, 1986, 320 (6062) : 535 - 537
  • [6] CYTOTOXIC LYMPHOCYTE-T RESPONSES IN THE PERIPHERAL-BLOOD OF CHILDREN BORN TO HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED MOTHERS
    CHEYNIER, R
    LANGLADEDEMOYEN, P
    MARESCOT, MR
    BLANCHE, S
    BLONDIN, G
    WAINHOBSON, S
    GRISCELLI, C
    VILMER, E
    PLATA, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (09) : 2211 - 2217
  • [7] DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123
  • [8] USE OF VACCINIA VIRUS VECTORS TO STUDY THE SYNTHESIS, INTRACELLULAR-LOCALIZATION, AND ACTION OF THE HUMAN IMMUNODEFICIENCY VIRUS TRANS-ACTIVATOR PROTEIN
    FALKNER, FG
    FUERST, TR
    MOSS, B
    [J]. VIROLOGY, 1988, 164 (02) : 450 - 457
  • [9] QUALITY-CONTROL IN THE FLOW CYTOMETRIC MEASUREMENT OF LYMPHOCYTE-T SUBSETS - THE MULTICENTER AIDS COHORT STUDY EXPERIENCE
    GIORGI, JV
    CHENG, HL
    MARGOLICK, JB
    BAUER, KD
    FERBAS, J
    WAXDAL, M
    SCHMID, I
    HULTIN, LE
    JACKSON, AL
    PARK, L
    TAYLOR, JMG
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (02): : 173 - 186
  • [10] EXPRESSION AND PROCESSING OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 GAG AND POL GENES BY CELLS INFECTED WITH A RECOMBINANT VACCINIA VIRUS
    GOWDA, SD
    STEIN, BS
    STEIMER, KS
    ENGLEMAN, EG
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (03) : 1451 - 1454